DoE- and PBBM-Driven Formulation Development of an Extended-Release Donepezil Tablet.

Pharmaceuticals (Basel) · 2025 · PMC12735571 · PMID 41471383

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

It also includes comments on highly significant interactions and uses the symbols (+) and (−) to denote the direction of each effect.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.